Revisión
Eventos adversos reumatológicos secundarios al uso de inhibidores de punto de control inmunitario
Rheumatological adverse events secondary to immune checkpoint inhibitors
Leído
8039
Vecesse ha leído el artículo
1584
Total PDF
6455
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 0 | 62 | 62 |
| 2025 9 | 0 | 77 | 77 |
| 2025 8 | 0 | 117 | 117 |
| 2025 7 | 0 | 93 | 93 |
| 2025 6 | 29 | 60 | 89 |
| 2025 5 | 814 | 100 | 914 |
| 2025 4 | 614 | 71 | 685 |
| 2025 3 | 654 | 86 | 740 |
| 2025 2 | 582 | 75 | 657 |
| 2025 1 | 455 | 78 | 533 |
| 2024 12 | 377 | 52 | 429 |
| 2024 11 | 421 | 113 | 534 |
| 2024 10 | 258 | 60 | 318 |
| 2024 9 | 266 | 51 | 317 |
| 2024 8 | 292 | 39 | 331 |
| 2024 7 | 239 | 41 | 280 |
| 2024 6 | 220 | 45 | 265 |
| 2024 5 | 224 | 59 | 283 |
| 2024 4 | 171 | 37 | 208 |
| 2024 3 | 148 | 62 | 210 |
| 2024 2 | 104 | 37 | 141 |
| 2024 1 | 163 | 26 | 189 |
| 2023 12 | 103 | 34 | 137 |
| 2023 11 | 126 | 47 | 173 |
| 2023 10 | 159 | 42 | 201 |
| 2023 9 | 2 | 1 | 3 |
| 2023 8 | 5 | 0 | 5 |
| 2023 7 | 1 | 2 | 3 |
| 2023 6 | 3 | 3 | 6 |
| 2023 5 | 5 | 3 | 8 |
| 2023 4 | 14 | 3 | 17 |
| 2023 3 | 1 | 5 | 6 |
| 2023 2 | 2 | 0 | 2 |
| 2022 1 | 2 | 2 | 4 |
| 2022 12 | 1 | 1 | 2 |
Mostrar todo
